Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Landos Biopharma (LABP) Q4 2023 Earnings
LABP
21
Mar
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.1
-0.76
-0.43
-0.09
Details
Expected EPS
-0.91
Actual EPS
-0.99
Surprise EPS
-0.08
Surprise Percent
+8.79%
Description
Landos Biopharma (LABP) has reported earnings of -0.99 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login